Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Going non-viral: theSleeping Beautytransposon system breaks on through to the clinical side

12 Apr 2017

Abstract excerpt

Molecular medicine has entered a high-tech age that provides curative treatments of complex genetic diseases through genetically engineered cellular medicinal products. Their clinical implementation requires the ability to stably integrate genetic information through gene transfer vectors in a safe, effective and economically viable manner. The latest generation of Sleeping Beauty (SB) transposon vectors fulfills...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to CRISPR and Genetic Engineering
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28402189
DOI: 10.1080/10409238.2017.1304354

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 20 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Going non-viral: theSleeping Beautytransposon system breaks on through to the clinical sidePMID 28402189Read ↗

Nonviral Gene Delivery with the <i>Sleeping Beauty</i> Transposon SystemSemantic proximity Read ↗

Sleeping Beauty Vector System Moves Toward Human Trials in the United StatesSemantic proximity Read ↗

Gene Therapy with the Sleeping Beauty Transposon SystemSemantic proximity Read ↗

Hyperactive transposase mutants of the Sleeping Beauty transposon.Semantic proximity Read ↗

Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapiesSemantic proximity Read ↗

A new approach to gene therapy using <i>Sleeping Beauty</i> to genetically modify clinical‐grade T cells to target <scp>CD</scp>19Semantic proximity Read ↗

Transposon-Based CAR T Cells in Acute Leukemias: Where Are We Going?Semantic proximity Read ↗

Efficient Non-Viral T-Cell Engineering by Sleeping Beauty Minicircles Diminishing DNA Toxicity and miRNAs Silencing the Endogenous T-Cell ReceptorsSemantic proximity Read ↗

RNA-guided Retargeting of <i>Sleeping Beauty</i> Transposition in Human CellsSemantic proximity Read ↗

Gene Therapy Leaves a Vicious CycleSemantic proximity Read ↗

Current Non-Viral-Based Strategies to Manufacture CAR-T CellsSemantic proximity Read ↗

The Past, Present, and Future of Non-Viral CAR T CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.